Dalteparin sodium injection treatment in patients with immunologic recurrent pregnancy loss.
Dalteparin sodium injection in patients with an immunologic component to RPL resulted in an increase in compliance without any adverse early pregnancy outcomes.
Trott
E A
EA
Delaware Institute for Reproductive Medicine, Milford, USA.
Trott
A M
AM
D000026:Abortion, Habitual / Q000188:drug therapy* / Q000276:immunology; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D017985:Dalteparin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology*; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D012189:Retrospective Studies
D000925:Anticoagulants; D017985:Dalteparin